Concourse Financial Group Securities, Inc. Forma Therapeutics Holdings, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$7.12 - $20.24 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$5.1 - $10.0 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$8.34 - $14.69 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$13.6 - $24.89 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$21.22 - $25.7 $0 - $0	0 New	0 $0

Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$24.58 - $42.82 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$34.9 - $51.08 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$32.95 - $50.25 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$39.0 - $46.49 $0 - $0	0 New	0 $0

Others Institutions Holding FMTX

# of Institutions

Shares Held

26.5K

Call Options Held

Put Options Held

View Full List

About Forma Therapeutics Holdings, Inc.

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

More about FMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account